Post-Marketing Surveillance on the Use of Prazaxa® Capsules in Japanese Patients With Nonvalvular Atrial Fibrillation After the Availability of Idarucizumab
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008448/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study objective is to confirm appropriate use and safety profile of Prazaxa® Capsules in
real-world setting after the availability of idarucizumab
提供机构：
Vivli
创建时间：
2022-09-30
